A Prospective, Clinical Study on Asymptomatic Sensitisation and Development of Allergic Rhinitis: High Negative Predictive Value of Allergological Testing
Background: Asymptomatic aeroallergen sensitisation affects approximately 10% of Western adolescents and is an established risk factor for the development of respiratory allergy. The reported incidence is 2–20% annually. Previous studies are based on out-seasonal symptom recollection or selected pop...
Saved in:
Published in | International archives of allergy and immunology Vol. 155; no. 3; pp. 289 - 296 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
Basel, Switzerland
Karger
01.01.2011
|
Subjects | |
Online Access | Get full text |
ISSN | 1018-2438 1423-0097 1423-0097 |
DOI | 10.1159/000320758 |
Cover
Abstract | Background: Asymptomatic aeroallergen sensitisation affects approximately 10% of Western adolescents and is an established risk factor for the development of respiratory allergy. The reported incidence is 2–20% annually. Previous studies are based on out-seasonal symptom recollection or selected populations, conferring bias towards higher incidence rates. Objective: The aim was to determine the incidence of onset of symptoms among clinically well-characterised asymptomatic, sensitised subjects compared with controls, and to evaluate the predictive values of common allergological tests. Methods: We performed a prospective, clinical, non-interventional, 2-year follow-up study on subjects (identified by population screening) with seasonal allergic birch or grass pollen rhinitis (n = 52), asymptomatic sensitisation to grass or birch (AS, n = 52) or non-atopic, healthy control subjects (n = 39). Experimental allergen susceptibility was assessed at inclusion and at follow-up by skin prick test, conjunctival challenge, intradermal late-phase reaction and measurement of specific IgE. Participants completed in-seasonal symptom and medication diaries during 2 subsequent seasons. Results: We observed an annual incidence rate of 5% for the onset of symptoms in the AS group (healthy control group 0%). At baseline, the AS group displayed intermediate experimental allergen susceptibility. Subjects developing symptoms had higher levels of specific IgE and larger late-phase reaction than those persistently asymptomatic. However, the positive predictive values were low (14–27%) in contrast to the negative predictive values (95–100%). Conclusion: In a well-characterised young population, asymptomatic aeroallergen sensitisation conferred a low risk for onset of symptoms during the 2-year follow-up. Persistent asymptomatic phenotype could be accurately predicted by negative results from simple allergological testing. |
---|---|
AbstractList | Background: Asymptomatic aeroallergen sensitisation affects approximately 10% of Western adolescents and is an established risk factor for the development of respiratory allergy. The reported incidence is 2–20% annually. Previous studies are based on out-seasonal symptom recollection or selected populations, conferring bias towards higher incidence rates. Objective: The aim was to determine the incidence of onset of symptoms among clinically well-characterised asymptomatic, sensitised subjects compared with controls, and to evaluate the predictive values of common allergological tests. Methods: We performed a prospective, clinical, non-interventional, 2-year follow-up study on subjects (identified by population screening) with seasonal allergic birch or grass pollen rhinitis (n = 52), asymptomatic sensitisation to grass or birch (AS, n = 52) or non-atopic, healthy control subjects (n = 39). Experimental allergen susceptibility was assessed at inclusion and at follow-up by skin prick test, conjunctival challenge, intradermal late-phase reaction and measurement of specific IgE. Participants completed in-seasonal symptom and medication diaries during 2 subsequent seasons. Results: We observed an annual incidence rate of 5% for the onset of symptoms in the AS group (healthy control group 0%). At baseline, the AS group displayed intermediate experimental allergen susceptibility. Subjects developing symptoms had higher levels of specific IgE and larger late-phase reaction than those persistently asymptomatic. However, the positive predictive values were low (14–27%) in contrast to the negative predictive values (95–100%). Conclusion: In a well-characterised young population, asymptomatic aeroallergen sensitisation conferred a low risk for onset of symptoms during the 2-year follow-up. Persistent asymptomatic phenotype could be accurately predicted by negative results from simple allergological testing. Asymptomatic aeroallergen sensitisation affects approximately 10% of Western adolescents and is an established risk factor for the development of respiratory allergy. The reported incidence is 2-20% annually. Previous studies are based on out-seasonal symptom recollection or selected populations, conferring bias towards higher incidence rates.BACKGROUNDAsymptomatic aeroallergen sensitisation affects approximately 10% of Western adolescents and is an established risk factor for the development of respiratory allergy. The reported incidence is 2-20% annually. Previous studies are based on out-seasonal symptom recollection or selected populations, conferring bias towards higher incidence rates.The aim was to determine the incidence of onset of symptoms among clinically well-characterised asymptomatic, sensitised subjects compared with controls, and to evaluate the predictive values of common allergological tests.OBJECTIVEThe aim was to determine the incidence of onset of symptoms among clinically well-characterised asymptomatic, sensitised subjects compared with controls, and to evaluate the predictive values of common allergological tests.We performed a prospective, clinical, non-interventional, 2-year follow-up study on subjects (identified by population screening) with seasonal allergic birch or grass pollen rhinitis (n = 52), asymptomatic sensitisation to grass or birch (AS, n = 52) or non-atopic, healthy control subjects (n = 39). Experimental allergen susceptibility was assessed at inclusion and at follow-up by skin prick test, conjunctival challenge, intradermal late-phase reaction and measurement of specific IgE. Participants completed in-seasonal symptom and medication diaries during 2 subsequent seasons.METHODSWe performed a prospective, clinical, non-interventional, 2-year follow-up study on subjects (identified by population screening) with seasonal allergic birch or grass pollen rhinitis (n = 52), asymptomatic sensitisation to grass or birch (AS, n = 52) or non-atopic, healthy control subjects (n = 39). Experimental allergen susceptibility was assessed at inclusion and at follow-up by skin prick test, conjunctival challenge, intradermal late-phase reaction and measurement of specific IgE. Participants completed in-seasonal symptom and medication diaries during 2 subsequent seasons.We observed an annual incidence rate of 5% for the onset of symptoms in the AS group (healthy control group 0%). At baseline, the AS group displayed intermediate experimental allergen susceptibility. Subjects developing symptoms had higher levels of specific IgE and larger late-phase reaction than those persistently asymptomatic. However, the positive predictive values were low (14-27%) in contrast to the negative predictive values (95-100%).RESULTSWe observed an annual incidence rate of 5% for the onset of symptoms in the AS group (healthy control group 0%). At baseline, the AS group displayed intermediate experimental allergen susceptibility. Subjects developing symptoms had higher levels of specific IgE and larger late-phase reaction than those persistently asymptomatic. However, the positive predictive values were low (14-27%) in contrast to the negative predictive values (95-100%).In a well-characterised young population, asymptomatic aeroallergen sensitisation conferred a low risk for onset of symptoms during the 2-year follow-up. Persistent asymptomatic phenotype could be accurately predicted by negative results from simple allergological testing.CONCLUSIONIn a well-characterised young population, asymptomatic aeroallergen sensitisation conferred a low risk for onset of symptoms during the 2-year follow-up. Persistent asymptomatic phenotype could be accurately predicted by negative results from simple allergological testing. Asymptomatic aeroallergen sensitisation affects approximately 10% of Western adolescents and is an established risk factor for the development of respiratory allergy. The reported incidence is 2-20% annually. Previous studies are based on out-seasonal symptom recollection or selected populations, conferring bias towards higher incidence rates. The aim was to determine the incidence of onset of symptoms among clinically well-characterised asymptomatic, sensitised subjects compared with controls, and to evaluate the predictive values of common allergological tests. We performed a prospective, clinical, non-interventional, 2-year follow-up study on subjects (identified by population screening) with seasonal allergic birch or grass pollen rhinitis (n = 52), asymptomatic sensitisation to grass or birch (AS, n = 52) or non-atopic, healthy control subjects (n = 39). Experimental allergen susceptibility was assessed at inclusion and at follow-up by skin prick test, conjunctival challenge, intradermal late-phase reaction and measurement of specific IgE. Participants completed in-seasonal symptom and medication diaries during 2 subsequent seasons. We observed an annual incidence rate of 5% for the onset of symptoms in the AS group (healthy control group 0%). At baseline, the AS group displayed intermediate experimental allergen susceptibility. Subjects developing symptoms had higher levels of specific IgE and larger late-phase reaction than those persistently asymptomatic. However, the positive predictive values were low (14-27%) in contrast to the negative predictive values (95-100%). In a well-characterised young population, asymptomatic aeroallergen sensitisation conferred a low risk for onset of symptoms during the 2-year follow-up. Persistent asymptomatic phenotype could be accurately predicted by negative results from simple allergological testing. Background: Asymptomatic aeroallergen sensitisation affects approximately 10% of Western adolescents and is an established risk factor for the development of respiratory allergy. The reported incidence is 2-20% annually. Previous studies are based on out-seasonal symptom recollection or selected populations, conferring bias towards higher incidence rates. Objective: The aim was to determine the incidence of onset of symptoms among clinically well-characterised asymptomatic, sensitised subjects compared with controls, and to evaluate the predictive values of common allergological tests. Methods: We performed a prospective, clinical, non-interventional, 2-year follow-up study on subjects (identified by population screening) with seasonal allergic birch or grass pollen rhinitis (n = 52), asymptomatic sensitisation to grass or birch (AS, n = 52) or non-atopic, healthy control subjects (n = 39). Experimental allergen susceptibility was assessed at inclusion and at follow-up by skin prick test, conjunctival challenge, intradermal late-phase reaction and measurement of specific IgE. Participants completed in-seasonal symptom and medication diaries during 2 subsequent seasons. Results: We observed an annual incidence rate of 5% for the onset of symptoms in the AS group (healthy control group 0%). At baseline, the AS group displayed intermediate experimental allergen susceptibility. Subjects developing symptoms had higher levels of specific IgE and larger late-phase reaction than those persistently asymptomatic. However, the positive predictive values were low (14-27%) in contrast to the negative predictive values (95-100%). Conclusion: In a well-characterised young population, asymptomatic aeroallergen sensitisation conferred a low risk for onset of symptoms during the 2-year follow-up. Persistent asymptomatic phenotype could be accurately predicted by negative results from simple allergological testing. Copyright [copy 2011 S. Karger AG, Basel |
Author | Poulsen, Lars K. Assing, Kristian Bodtger, Uffe |
Author_xml | – sequence: 1 givenname: Uffe surname: Bodtger fullname: Bodtger, Uffe email: uffe.bodtger@dadlnet.dk – sequence: 2 givenname: Kristian surname: Assing fullname: Assing, Kristian – sequence: 3 givenname: Lars K. surname: Poulsen fullname: Poulsen, Lars K. |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=24284970$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/21293149$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkVuL1TAUhYOMOBd98F0kLyKCdXbT9CT17XC8jDCoOKOvJU13O9G0qUk6cP6Kv9aci2dABJ-SsL-1FtnrlByNbkRCHufwKs_L6hwACgailPfISc5ZkQFU4ijdIZcZ44U8JqchfAdIsFw8IMcsZ1WR8-qE_FrSz96FCXU0t_iSrqwZjVaWXsW5XVM30mVYD1N0g4pG0yscg4kmpEcaqbGlb_AWrZsGHCN1HV1ai75P5JebZJTI1_TC9Df0I_Zqk5DSsDXbMPpN2RnvRM66fht9jSGasX9I7nfKBny0P8_I13dvr1cX2eWn9x9Wy8tMFwsRMyZ0pQViyQRKJSoum0Y1jHGADjRq3eq2AdkpobDhaQEAYqHKhWZSyrKrijPyfOc7efdzTtn1YIJGa9WIbg61lAUkMyj_TwrGOQgJiXy6J-dmwLaevBmUX9d_Fp-AZ3tAhfTnzqtRm3DHcSZ5JTZGL3acTi0Fj90ByaHelF8fyk_s-V-sNnHbVPTK2H8qnuwUP5Tv0R-89-Pfdtq6cw |
CitedBy_id | crossref_primary_10_1097_WOX_0b013e318232df96 crossref_primary_10_2500_ajra_2012_26_3790 crossref_primary_10_1016_j_anai_2013_02_010 crossref_primary_10_1183_09031936_00153013 crossref_primary_10_53529_2500_1175_2021_3_40_48 crossref_primary_10_1017_S0007114513001505 crossref_primary_10_2217_epi_13_68 crossref_primary_10_1111_all_13630 crossref_primary_10_1111_cea_12607 crossref_primary_10_1159_000322237 |
Cites_doi | 10.1016%2Fj.jaci.2005.05.017 10.1016%2FS0091-6749%2897%2970170-2 10.1007%2FBF00453546 10.1111%2Fj.1398-9995.1998.tb03954.x 10.1111%2Fj.1365-2249.2008.03712.x 10.1111%2Fj.1398-9995.2009.02169.x 10.1046%2Fj.1365-2222.1999.00567.x 10.1034%2Fj.1398-9995.2000.00367.x 10.1034%2Fj.1398-9995.2002.1o3532.x 10.1111%2Fj.1398-9995.2006.01140.x 10.1046%2Fj.1398-9995.2003.00323.x 10.1111%2Fj.1398-9995.1984.tb01931.x 10.1067%2Fmai.2003.37 10.1016%2Fj.spinee.2008.11.002 10.1111%2Fj.1365-2222.2006.02594.x 10.2174%2F187152808786848405 10.1111%2Fj.1398-9995.2004.00457.x 10.1111%2Fj.1399-3038.2008.00805.x 10.1016%2F0021-8707%2858%2990009-1 10.1111%2Fj.1398-9995.1993.tb04756.x 10.1016%2F0304-3959%2893%2990079-5 10.1016%2F0021-8707%2869%2990024-0 10.1111%2Fj.1398-9995.2006.01280.x 10.1158%2F1055-9965.EPI-07-2629 10.1034%2Fj.1399-3038.2003.00024.x 10.1111%2Fj.1398-9995.2007.01517.x 10.1034%2Fj.1398-9995.2002.12945.x 10.1046%2Fj.1365-2222.2003.01611.x 10.1111%2Fj.1365-2222.1992.tb02829.x 10.1111%2Fj.1365-2222.2006.02435.x 10.1067%2Fmai.2000.108312 10.2500%2F108854194778816634 10.1111%2Fj.1398-9995.2006.01084.x |
ContentType | Journal Article |
Copyright | 2011 S. Karger AG, Basel 2015 INIST-CNRS Copyright © 2011 S. Karger AG, Basel. |
Copyright_xml | – notice: 2011 S. Karger AG, Basel – notice: 2015 INIST-CNRS – notice: Copyright © 2011 S. Karger AG, Basel. |
DBID | AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 7X8 7T5 H94 |
DOI | 10.1159/000320758 |
DatabaseName | CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic Immunology Abstracts AIDS and Cancer Research Abstracts |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic AIDS and Cancer Research Abstracts Immunology Abstracts |
DatabaseTitleList | MEDLINE - Academic MEDLINE AIDS and Cancer Research Abstracts CrossRef |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1423-0097 |
EndPage | 296 |
ExternalDocumentID | 21293149 24284970 10_1159_000320758 320758 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GeographicLocations | Denmark |
GeographicLocations_xml | – name: Denmark |
GroupedDBID | --- .55 .GJ 0R~ 0~5 0~B 29J 30W 328 34G 36B 39C 3O- 3O. 3V. 4.4 53G 5GY 5RE 7X7 88E 8AO 8FE 8FH 8FI 8FJ 8G5 8UI AAYIC ABJNI ABOCM ABPAZ ABUWG ACGFS ACPRK ACPSR ADAGL ADBBV AENEX AEYAO AFDXO AFFNX AFJJK AFKRA AFRAH AHMBA ALDHI ALIPV ALMA_UNASSIGNED_HOLDINGS AZPMC AZQEC BBNVY BENPR BHPHI BPHCQ BVXVI CAG CCPQU COF CS3 CYUIP DU5 DWQXO E0A EBS EJD EMB EMOBN F5P FB. FYUFA GNUQQ GUQSH HCIFZ HMCUK HZ~ IAO IHR IHW INH IY7 KUZGX L7B LK8 M1P M2O M7P N9A O1H O9- PQQKQ PROAC PSQYO RIG RKO RXVBD SV3 UJ6 UKHRP X7M ZGI ZXP AAYXX ABBTS ABWCG ACQXL AFSIO AHFRZ CITATION ITC PHGZM PHGZT PJZUB PPXIY PQGLB PUEGO IQODW CGR CUY CVF ECM EIF NPM 7X8 7T5 H94 |
ID | FETCH-LOGICAL-c367t-27c9c7ee527e8a7948bbab22400f0ceccdcdb08fa7aeb45980076a56c28885f93 |
ISSN | 1018-2438 1423-0097 |
IngestDate | Thu Sep 04 20:04:30 EDT 2025 Fri Sep 05 07:55:05 EDT 2025 Mon Jul 21 05:55:13 EDT 2025 Mon Jul 21 09:18:11 EDT 2025 Wed Sep 10 04:47:41 EDT 2025 Thu Apr 24 22:52:30 EDT 2025 Thu Aug 29 12:04:42 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Keywords | Sensitisation to allergens Immunoglobulin E Allergen challenge Seasonal allergic rhinitis Risk assessment Allergy Immunopathology Nose disease Rhinitis IgE Risk Asymptomatic Medical screening Prospective Immunology Risk factor Predictive value ENT disease Allergen Provocation test |
Language | English |
License | Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. https://www.karger.com/Services/SiteLicenses CC BY 4.0 Copyright © 2011 S. Karger AG, Basel. |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c367t-27c9c7ee527e8a7948bbab22400f0ceccdcdb08fa7aeb45980076a56c28885f93 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 21293149 |
PQID | 872440780 |
PQPubID | 23479 |
PageCount | 8 |
ParticipantIDs | proquest_miscellaneous_883040005 crossref_citationtrail_10_1159_000320758 crossref_primary_10_1159_000320758 proquest_miscellaneous_872440780 pubmed_primary_21293149 pascalfrancis_primary_24284970 karger_primary_320758 |
PublicationCentury | 2000 |
PublicationDate | 2011-01-01 |
PublicationDateYYYYMMDD | 2011-01-01 |
PublicationDate_xml | – month: 01 year: 2011 text: 2011-01-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | Basel, Switzerland |
PublicationPlace_xml | – name: Basel, Switzerland – name: Basel – name: Switzerland |
PublicationTitle | International archives of allergy and immunology |
PublicationTitleAlternate | Int Arch Allergy Immunol |
PublicationYear | 2011 |
Publisher | Karger |
Publisher_xml | – name: Karger |
References | Dreborg S, Frew AJ: Allergen standardization and skin tests. Allergy 1993;48(suppl 14):49–82.10.1111%2Fj.1398-9995.1993.tb04756.x Bodtger U, Poulsen LK, Malling HJ: Asymptomatic skin sensitization to birch predicts later development of birch pollen allergy in adults: a 3-year follow-up study. J Allergy Clin Immunol 2003;111:149–154.1253211110.1067%2Fmai.2003.37 Bodtger U, Poulsen LK, Jacobi HH, Malling HJ: The safety and efficacy of subcutaneous birch pollen immunotherapy – a one-year, randomised, double-blind, placebo-controlled study. Allergy 2002;57:297–305.1190635910.1034%2Fj.1398-9995.2002.1o3532.x Schappi GF, Suphioglu C, Taylor PE, Knox RB: Concentrations of the major birch tree allergen Bet v 1 in pollen and respirable fine particles in the atmosphere. J Allergy Clin Immunol 1997;100:656–661.938929610.1016%2FS0091-6749%2897%2970170-2 Bodtger U, Poulsen LK, Linneberg A: Rhinitis symptoms and IgE sensitization as risk factors for development of later allergic rhinitis in adults. Allergy 2006;61:712–716.1667724010.1111%2Fj.1398-9995.2006.01140.x Altman DG: Practical Statistics for Medical Research, ed 1. New York, Chapman & Hall, 1992. Rasmussen A, Sommer J: Pollen: how are the pollen counts performed. Copenhagen, Danish Meteorological Institute, 2010. http://www.dmi.dk/eng/index/research_and_development/pollen-4.htm. Bufe A, Ziegler-Kirbach E, Stoeckmann E, Heidemann P, Gehlhar K, Holland-Letz T, Braun W: Efficacy of sublingual swallow immunotherapy in children with severe grass pollen allergic symptoms: a double-blind placebo-controlled study. Allergy 2004;59:498–504.1508083010.1111%2Fj.1398-9995.2004.00457.x Bodtger U, Jacobsen CR, Poulsen LK, Malling HJ: Long-term repeatability of the skin prick test is high when supported by history or allergen-sensitivity tests: a prospective clinical study. Allergy 2003;58:1180–1186.1461613110.1046%2Fj.1398-9995.2003.00323.x Grow MH, Herman NB: Intracutaneous test in normal individuals. J Allergy 1935;36:108–111. Remes ST, Korppi M, Kajosaari M, Koivikko A, Soininen L, Pekkanen J: Prevalence of allergic rhinitis and atopic dermatitis among children in four regions of Finland. Allergy 1998;53:682–689.970003710.1111%2Fj.1398-9995.1998.tb03954.x Bodtger U, Poulsen LK, Malling HJ: Retrospective assessment of seasonal allergic symptoms: over-rating but useful. Clin Exp Allergy 2003;33:496–500.1268086610.1046%2Fj.1365-2222.2003.01611.x Beese A, Morley S: Memory for acute pain experience is specifically inaccurate but generally reliable. Pain 1993;53:183–189.833698810.1016%2F0304-3959%2893%2990079-5 Winther L, Malling HJ, Moseholm L, Mosbech H: Allergen-specific immunotherapy in birch- and grass-pollen-allergic rhinitis. 1. Efficacy estimated by a model reducing the bias of annual differences in pollen counts. Allergy 2000;55:818–826.1100344510.1034%2Fj.1398-9995.2000.00367.x Linneberg A, Nielsen NH, Madsen F, Frolund L, Dirksen A, Jorgensen T: Increasing prevalence of specific IgE to aeroallergens in an adult population: two cross-sectional surveys 8 years apart. The Copenhagen Allergy Study. J Allergy Clin Immunol 2000;106:247–252.1093206610.1067%2Fmai.2000.108312 Rasmussen A: Pollen counts in Copenhagen, Denmark: archive data, 1978–2007. Danish Meteorological Institute. 2010. http://www.dmi.dk/dmi/index/viden/pollen/pollenoversigt-totaler.htm. Pucci S, Incorvaia C: Allergy as an organ and a systemic disease. Clin Exp Immunol 2008;153(suppl 1):1–2.1872132010.1111%2Fj.1365-2249.2008.03712.x Hagy GW, Settipane GA: Bronchial asthma, allergic rhinitis, and allergy skin tests among college students. J Allergy 1969;44:323–332.526188510.1016%2F0021-8707%2869%2990024-0 Radcliffe MJ, Lewith GT, Prescott P, Church MK, Holgate ST: Do skin prick and conjunctival provocation tests predict symptom severity in seasonal allergic rhinoconjunctivitis? Clin Exp Allergy 2006;36:1488–1493.1717767110.1111%2Fj.1365-2222.2006.02594.x Don AS, Carragee EJ: Is the self-reported history accurate in patients with persistent axial pain after a motor vehicle accident? Spine J 2009;9:4–12.1911125810.1016%2Fj.spinee.2008.11.002 Bousquet PJ, Burbach G, Heinzerling LM, Edenharter G, Bachert C, Bindslev-Jensen C, Bonini S, Bousquet-Rouanet L, Demoly P, Bresciani M, Bruno A, Gjomarkaj M, Canonica GW, Darsow U, Durham S, Fokkens WJ, Giavi S, Gramiccioni C, Papadopoulos NG, Haahtela T, Kowalski ML, Magyar P, Murakozi G, Orosz M, Rohnelt C, Stingl G, Todo-Bom A, von Mutius E, Wiesner A, Wohrl S, Bousquet J, Zuberbier T: GA2LEN skin test study III: minimum battery of test inhalent allergens needed in epidemiological studies in patients. Allergy 2009;64:1656–1662.1982488710.1111%2Fj.1398-9995.2009.02169.x Assing K, Nielsen CH, Poulsen LK: Immunological characteristics of subjects with asymptomatic skin sensitization to birch and grass pollen. Clin Exp Allergy 2006;36:283–292.1649963810.1111%2Fj.1365-2222.2006.02435.x Assing K, Bodtger U, Poulsen LK, Malling HJ: Grass pollen symptoms interfere with the recollection of birch pollen symptoms – a prospective study of suspected, asymptomatic skin sensitization. Allergy 2007;62:373–377.1736224710.1111%2Fj.1398-9995.2006.01280.x Schäfer T, Hoelscher B, Adam H, Ring J, Wichmann HE, Heinrich J: Hay fever and predictive value of prick test and specific IgE antibodies: a prospective study in children. Pediatr Allergy Immunol 2003;14:120–129.1267575810.1034%2Fj.1399-3038.2003.00024.x Riedinger F, Kuehr J, Strauch E, Schulz H, Ihorst G, Forster J: Natural history of hay fever and pollen sensitization, and doctors’ diagnosis of hay fever and pollen asthma in German schoolchildren. Allergy 2002;57:488–492.1202811310.1034%2Fj.1398-9995.2002.12945.x Chambers VV, Glaser J: The incidence of subsequent ragweed pollinosis in symptom-free persons having positive reactions to ragweed pollen extract. J Allergy 1958;29:249–257.1353861910.1016%2F0021-8707%2858%2990009-1 Horak F: Manifestation of allergic rhinitis in latent-sensitized patients. A prospective study. Arch Otorhinolaryngol 1985;242:239–245.407418210.1007%2FBF00453546 Nouri-Aria KT, Durham SR: Regulatory T cells and allergic disease. Inflamm Allergy Drug Targets 2008;7:237–252.1907578910.2174%2F187152808786848405 Assing K, Bodtger U, Poulsen LK: Seasonal dynamics of chemokine receptors and CD62L in subjects with asymptomatic skin sensitization to birch and grass pollen. Allergy 2006;61:759–768.1667724710.1111%2Fj.1398-9995.2006.01084.x Rauscher GH, Johnson TP, Cho YI, Walk JA: Accuracy of self-reported cancer-screening histories: a meta-analysis. Cancer Epidemiol Biomarkers Prev 2008;17:748–757.1838146810.1158%2F1055-9965.EPI-07-2629 Schäfer Y, Schäfer T, Meisinger C, Wichmann HE, Heinrich J: Predictivity of allergic sensitization (RAST) for the onset of allergic diseases in adults. Allergy 2008;63:81–86.1805301710.1111%2Fj.1398-9995.2007.01517.x Arbes SJ Jr, Gergen PJ, Elliott L, Zeldin DC: Prevalences of positive skin test responses to 10 common allergens in the US population: results from the third National Health and Nutrition Examination Survey. J Allergy Clin Immunol 2005;116:377–383.1608379310.1016%2Fj.jaci.2005.05.017 Schappi GF, Taylor PE, Pain MC, Cameron PA, Dent AW, Staff IA, Suphioglu C: Concentrations of major grass group 5 allergens in pollen grains and atmospheric particles: implications for hay fever and allergic asthma sufferers sensitized to grass pollen allergens. Clin Exp Allergy 1999;29:633–641.1023132310.1046%2Fj.1365-2222.1999.00567.x Govaere E, Van Gysel D, Verhamme KM, Doli E, De Baets F: The association of allergic symptoms with sensitization to inhalant allergens in childhood. Pediatr Allergy Immunol 2009;20:448–457.1917588810.1111%2Fj.1399-3038.2008.00805.x Moller C, Bjorksten B, Nilsson G, Dreborg S: The precision of the conjunctival provocation test. Allergy 1984;39:37–41.669620910.1111%2Fj.1398-9995.1984.tb01931.x Settipane RJ, Hagy GW, Settipane GA: Long-term risk factors for developing asthma and allergic rhinitis: a 23-year follow-up study of college students. Allergy Proc 1994;15:21–25.800545210.2500%2F108854194778816634 Kuehr J, Karmaus W, Frischer T, Hendel-Kramer A, Weiss K, Moseler M, Stephan V, Forster J, Urbanek R: Longitudinal variability of skin prick test results. Clin Exp Allergy 1992;22:839–844.142294110.1111%2Fj.1365-2222.1992.tb02829.x ref13 ref12 ref15 ref14 ref31 ref30 ref11 ref33 ref10 ref32 ref2 ref1 ref17 ref16 ref19 ref18 ref24 ref23 ref26 ref25 ref20 ref22 ref21 ref28 ref27 ref29 ref8 ref7 ref9 ref4 ref3 ref6 ref5 21293139 - Int Arch Allergy Immunol. 2011;155(3):189-90 |
References_xml | – reference: Govaere E, Van Gysel D, Verhamme KM, Doli E, De Baets F: The association of allergic symptoms with sensitization to inhalant allergens in childhood. Pediatr Allergy Immunol 2009;20:448–457.1917588810.1111%2Fj.1399-3038.2008.00805.x – reference: Assing K, Bodtger U, Poulsen LK, Malling HJ: Grass pollen symptoms interfere with the recollection of birch pollen symptoms – a prospective study of suspected, asymptomatic skin sensitization. Allergy 2007;62:373–377.1736224710.1111%2Fj.1398-9995.2006.01280.x – reference: Winther L, Malling HJ, Moseholm L, Mosbech H: Allergen-specific immunotherapy in birch- and grass-pollen-allergic rhinitis. 1. Efficacy estimated by a model reducing the bias of annual differences in pollen counts. Allergy 2000;55:818–826.1100344510.1034%2Fj.1398-9995.2000.00367.x – reference: Nouri-Aria KT, Durham SR: Regulatory T cells and allergic disease. Inflamm Allergy Drug Targets 2008;7:237–252.1907578910.2174%2F187152808786848405 – reference: Bodtger U, Jacobsen CR, Poulsen LK, Malling HJ: Long-term repeatability of the skin prick test is high when supported by history or allergen-sensitivity tests: a prospective clinical study. Allergy 2003;58:1180–1186.1461613110.1046%2Fj.1398-9995.2003.00323.x – reference: Dreborg S, Frew AJ: Allergen standardization and skin tests. Allergy 1993;48(suppl 14):49–82.10.1111%2Fj.1398-9995.1993.tb04756.x – reference: Hagy GW, Settipane GA: Bronchial asthma, allergic rhinitis, and allergy skin tests among college students. J Allergy 1969;44:323–332.526188510.1016%2F0021-8707%2869%2990024-0 – reference: Settipane RJ, Hagy GW, Settipane GA: Long-term risk factors for developing asthma and allergic rhinitis: a 23-year follow-up study of college students. Allergy Proc 1994;15:21–25.800545210.2500%2F108854194778816634 – reference: Assing K, Bodtger U, Poulsen LK: Seasonal dynamics of chemokine receptors and CD62L in subjects with asymptomatic skin sensitization to birch and grass pollen. Allergy 2006;61:759–768.1667724710.1111%2Fj.1398-9995.2006.01084.x – reference: Beese A, Morley S: Memory for acute pain experience is specifically inaccurate but generally reliable. Pain 1993;53:183–189.833698810.1016%2F0304-3959%2893%2990079-5 – reference: Linneberg A, Nielsen NH, Madsen F, Frolund L, Dirksen A, Jorgensen T: Increasing prevalence of specific IgE to aeroallergens in an adult population: two cross-sectional surveys 8 years apart. The Copenhagen Allergy Study. J Allergy Clin Immunol 2000;106:247–252.1093206610.1067%2Fmai.2000.108312 – reference: Bufe A, Ziegler-Kirbach E, Stoeckmann E, Heidemann P, Gehlhar K, Holland-Letz T, Braun W: Efficacy of sublingual swallow immunotherapy in children with severe grass pollen allergic symptoms: a double-blind placebo-controlled study. Allergy 2004;59:498–504.1508083010.1111%2Fj.1398-9995.2004.00457.x – reference: Chambers VV, Glaser J: The incidence of subsequent ragweed pollinosis in symptom-free persons having positive reactions to ragweed pollen extract. J Allergy 1958;29:249–257.1353861910.1016%2F0021-8707%2858%2990009-1 – reference: Kuehr J, Karmaus W, Frischer T, Hendel-Kramer A, Weiss K, Moseler M, Stephan V, Forster J, Urbanek R: Longitudinal variability of skin prick test results. Clin Exp Allergy 1992;22:839–844.142294110.1111%2Fj.1365-2222.1992.tb02829.x – reference: Bodtger U, Poulsen LK, Linneberg A: Rhinitis symptoms and IgE sensitization as risk factors for development of later allergic rhinitis in adults. Allergy 2006;61:712–716.1667724010.1111%2Fj.1398-9995.2006.01140.x – reference: Schappi GF, Suphioglu C, Taylor PE, Knox RB: Concentrations of the major birch tree allergen Bet v 1 in pollen and respirable fine particles in the atmosphere. J Allergy Clin Immunol 1997;100:656–661.938929610.1016%2FS0091-6749%2897%2970170-2 – reference: Radcliffe MJ, Lewith GT, Prescott P, Church MK, Holgate ST: Do skin prick and conjunctival provocation tests predict symptom severity in seasonal allergic rhinoconjunctivitis? Clin Exp Allergy 2006;36:1488–1493.1717767110.1111%2Fj.1365-2222.2006.02594.x – reference: Bousquet PJ, Burbach G, Heinzerling LM, Edenharter G, Bachert C, Bindslev-Jensen C, Bonini S, Bousquet-Rouanet L, Demoly P, Bresciani M, Bruno A, Gjomarkaj M, Canonica GW, Darsow U, Durham S, Fokkens WJ, Giavi S, Gramiccioni C, Papadopoulos NG, Haahtela T, Kowalski ML, Magyar P, Murakozi G, Orosz M, Rohnelt C, Stingl G, Todo-Bom A, von Mutius E, Wiesner A, Wohrl S, Bousquet J, Zuberbier T: GA2LEN skin test study III: minimum battery of test inhalent allergens needed in epidemiological studies in patients. Allergy 2009;64:1656–1662.1982488710.1111%2Fj.1398-9995.2009.02169.x – reference: Rasmussen A: Pollen counts in Copenhagen, Denmark: archive data, 1978–2007. Danish Meteorological Institute. 2010. http://www.dmi.dk/dmi/index/viden/pollen/pollenoversigt-totaler.htm. – reference: Horak F: Manifestation of allergic rhinitis in latent-sensitized patients. A prospective study. Arch Otorhinolaryngol 1985;242:239–245.407418210.1007%2FBF00453546 – reference: Pucci S, Incorvaia C: Allergy as an organ and a systemic disease. Clin Exp Immunol 2008;153(suppl 1):1–2.1872132010.1111%2Fj.1365-2249.2008.03712.x – reference: Schappi GF, Taylor PE, Pain MC, Cameron PA, Dent AW, Staff IA, Suphioglu C: Concentrations of major grass group 5 allergens in pollen grains and atmospheric particles: implications for hay fever and allergic asthma sufferers sensitized to grass pollen allergens. Clin Exp Allergy 1999;29:633–641.1023132310.1046%2Fj.1365-2222.1999.00567.x – reference: Schäfer Y, Schäfer T, Meisinger C, Wichmann HE, Heinrich J: Predictivity of allergic sensitization (RAST) for the onset of allergic diseases in adults. Allergy 2008;63:81–86.1805301710.1111%2Fj.1398-9995.2007.01517.x – reference: Schäfer T, Hoelscher B, Adam H, Ring J, Wichmann HE, Heinrich J: Hay fever and predictive value of prick test and specific IgE antibodies: a prospective study in children. Pediatr Allergy Immunol 2003;14:120–129.1267575810.1034%2Fj.1399-3038.2003.00024.x – reference: Moller C, Bjorksten B, Nilsson G, Dreborg S: The precision of the conjunctival provocation test. Allergy 1984;39:37–41.669620910.1111%2Fj.1398-9995.1984.tb01931.x – reference: Altman DG: Practical Statistics for Medical Research, ed 1. New York, Chapman & Hall, 1992. – reference: Bodtger U, Poulsen LK, Jacobi HH, Malling HJ: The safety and efficacy of subcutaneous birch pollen immunotherapy – a one-year, randomised, double-blind, placebo-controlled study. Allergy 2002;57:297–305.1190635910.1034%2Fj.1398-9995.2002.1o3532.x – reference: Grow MH, Herman NB: Intracutaneous test in normal individuals. J Allergy 1935;36:108–111. – reference: Don AS, Carragee EJ: Is the self-reported history accurate in patients with persistent axial pain after a motor vehicle accident? Spine J 2009;9:4–12.1911125810.1016%2Fj.spinee.2008.11.002 – reference: Rasmussen A, Sommer J: Pollen: how are the pollen counts performed. Copenhagen, Danish Meteorological Institute, 2010. http://www.dmi.dk/eng/index/research_and_development/pollen-4.htm. – reference: Bodtger U, Poulsen LK, Malling HJ: Asymptomatic skin sensitization to birch predicts later development of birch pollen allergy in adults: a 3-year follow-up study. J Allergy Clin Immunol 2003;111:149–154.1253211110.1067%2Fmai.2003.37 – reference: Bodtger U, Poulsen LK, Malling HJ: Retrospective assessment of seasonal allergic symptoms: over-rating but useful. Clin Exp Allergy 2003;33:496–500.1268086610.1046%2Fj.1365-2222.2003.01611.x – reference: Rauscher GH, Johnson TP, Cho YI, Walk JA: Accuracy of self-reported cancer-screening histories: a meta-analysis. Cancer Epidemiol Biomarkers Prev 2008;17:748–757.1838146810.1158%2F1055-9965.EPI-07-2629 – reference: Riedinger F, Kuehr J, Strauch E, Schulz H, Ihorst G, Forster J: Natural history of hay fever and pollen sensitization, and doctors’ diagnosis of hay fever and pollen asthma in German schoolchildren. Allergy 2002;57:488–492.1202811310.1034%2Fj.1398-9995.2002.12945.x – reference: Assing K, Nielsen CH, Poulsen LK: Immunological characteristics of subjects with asymptomatic skin sensitization to birch and grass pollen. Clin Exp Allergy 2006;36:283–292.1649963810.1111%2Fj.1365-2222.2006.02435.x – reference: Remes ST, Korppi M, Kajosaari M, Koivikko A, Soininen L, Pekkanen J: Prevalence of allergic rhinitis and atopic dermatitis among children in four regions of Finland. Allergy 1998;53:682–689.970003710.1111%2Fj.1398-9995.1998.tb03954.x – reference: Arbes SJ Jr, Gergen PJ, Elliott L, Zeldin DC: Prevalences of positive skin test responses to 10 common allergens in the US population: results from the third National Health and Nutrition Examination Survey. J Allergy Clin Immunol 2005;116:377–383.1608379310.1016%2Fj.jaci.2005.05.017 – ident: ref11 doi: 10.1016%2Fj.jaci.2005.05.017 – ident: ref21 doi: 10.1016%2FS0091-6749%2897%2970170-2 – ident: ref8 doi: 10.1007%2FBF00453546 – ident: ref24 doi: 10.1111%2Fj.1398-9995.1998.tb03954.x – ident: ref33 doi: 10.1111%2Fj.1365-2249.2008.03712.x – ident: ref13 doi: 10.1111%2Fj.1398-9995.2009.02169.x – ident: ref22 doi: 10.1046%2Fj.1365-2222.1999.00567.x – ident: ref23 doi: 10.1034%2Fj.1398-9995.2000.00367.x – ident: ref17 doi: 10.1034%2Fj.1398-9995.2002.1o3532.x – ident: ref2 doi: 10.1111%2Fj.1398-9995.2006.01140.x – ident: ref29 doi: 10.1046%2Fj.1398-9995.2003.00323.x – ident: ref20 doi: 10.1111%2Fj.1398-9995.1984.tb01931.x – ident: ref7 doi: 10.1067%2Fmai.2003.37 – ident: ref27 doi: 10.1016%2Fj.spinee.2008.11.002 – ident: ref31 doi: 10.1111%2Fj.1365-2222.2006.02594.x – ident: ref32 doi: 10.2174%2F187152808786848405 – ident: ref18 doi: 10.1111%2Fj.1398-9995.2004.00457.x – ident: ref1 doi: 10.1111%2Fj.1399-3038.2008.00805.x – ident: ref9 doi: 10.1016%2F0021-8707%2858%2990009-1 – ident: ref19 doi: 10.1111%2Fj.1398-9995.1993.tb04756.x – ident: ref26 doi: 10.1016%2F0304-3959%2893%2990079-5 – ident: ref10 doi: 10.1016%2F0021-8707%2869%2990024-0 – ident: ref14 doi: 10.1111%2Fj.1398-9995.2006.01280.x – ident: ref28 doi: 10.1158%2F1055-9965.EPI-07-2629 – ident: ref4 doi: 10.1034%2Fj.1399-3038.2003.00024.x – ident: ref3 doi: 10.1111%2Fj.1398-9995.2007.01517.x – ident: ref6 doi: 10.1034%2Fj.1398-9995.2002.12945.x – ident: ref25 doi: 10.1046%2Fj.1365-2222.2003.01611.x – ident: ref30 doi: 10.1111%2Fj.1365-2222.1992.tb02829.x – ident: ref12 doi: 10.1111%2Fj.1365-2222.2006.02435.x – ident: ref15 doi: 10.1067%2Fmai.2000.108312 – ident: ref5 doi: 10.2500%2F108854194778816634 – ident: ref16 doi: 10.1111%2Fj.1398-9995.2006.01084.x – reference: 21293139 - Int Arch Allergy Immunol. 2011;155(3):189-90 |
SSID | ssj0015986 |
Score | 1.9942454 |
Snippet | Background: Asymptomatic aeroallergen sensitisation affects approximately 10% of Western adolescents and is an established risk factor for the development of... Asymptomatic aeroallergen sensitisation affects approximately 10% of Western adolescents and is an established risk factor for the development of respiratory... |
SourceID | proquest pubmed pascalfrancis crossref karger |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 289 |
SubjectTerms | Adult Allergens - immunology Betula - immunology Biological and medical sciences Denmark - epidemiology Female Fundamental and applied biological sciences. Psychology Fundamental immunology Humans Immunoglobulin E - blood Immunopathology Incidence Male Medical sciences Middle Aged Non tumoral diseases Original Paper Otorhinolaryngology. Stomatology Poaceae - immunology Pollen - immunology Predictive Value of Tests Prospective Studies Rhinitis, Allergic, Seasonal - diagnosis Rhinitis, Allergic, Seasonal - epidemiology Rhinitis, Allergic, Seasonal - immunology Sarcoidosis. Granulomatous diseases of unproved etiology. Connective tissue diseases. Elastic tissue diseases. Vasculitis Sensitivity and Specificity Skin Tests Upper respiratory tract, upper alimentary tract, paranasal sinuses, salivary glands: diseases, semeiology Young Adult |
Title | A Prospective, Clinical Study on Asymptomatic Sensitisation and Development of Allergic Rhinitis: High Negative Predictive Value of Allergological Testing |
URI | https://karger.com/doi/10.1159/000320758 https://www.ncbi.nlm.nih.gov/pubmed/21293149 https://www.proquest.com/docview/872440780 https://www.proquest.com/docview/883040005 |
Volume | 155 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLbKhhAviMuAcqksxAMSZMvdDm8dGpq4TBNrUd8qJ7HLoCRTmz7AT-H_8L84viZhAw1eosi1ozbf13OO7e8cI_S0DAjEyVKKUyahFwcF8zIquMdTRv2ElyllSm1xlB5O4zezZDYY_OyoljZNvlt8vzCv5H9QhTbAVWbJ_gOy7qHQAPeAL1wBYbheCuOx1PnbXEm15GnzHE90regKXv-3r2dNrQuznki1emMEPEaE7DRDKiaViYELqa3_dCpVRUovJ6UgYAwXukT48Upu7ajbj2y54e0wZ0YnsnKH8YifW6V8u_DIOuVumRprqkDJZJXeOv9-XTYLzaqpEC091-vTvpFyJr7eLM2i0juYsz9_u9td11DZfXZdQ5tiPwC0Y137ZZfrNgj-PJl60rPfus6vIWrUtcb6dCLj2EN9dO55n5FkWmQZhRA_0dYxWjHAb_7SqRjV_CnJ5m7oFbQdEgjhwKySmZv3B7IEvtp0Nz_IFLiC9j03tBcWXf0iswBWUqfL1oCb0Ges_HkSpIKhyU10w8xi8FhT8hYa8Oo2uvbe6DTuoB9j3GHmC2x5iRUvcV3hLi9xj5cYmIA7vMS1wJaX2PLyJZasxJaVuGUlVqxsB1lWYsPKHTR9fTB5deiZU0C8IkpJ44WkyArCeRISThm4D5rnLFfaZ-EXYIHKosx9KhhhPI_hXcvNZZakRUgpTUQW3UVbVV3x-wiDgwry1Oeh8LM4jQgVeRRwQbM8TMIyz4bomQVhXpgS-fKkluX8HNRD9MR1PdN1YS7qtKORdF1s-6gHrPsY4mUaZ8QfImyRnoO5l3t4rOL1Zj2nBOJxCOv_1oVG0jP7yRDd0yRpny-j-yDOHlzm2z9E19v_5SO01aw2_DFE4E0-Uvweoe39g6PjD78A433ghw |
linkProvider | ProQuest |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+Prospective%2C+Clinical+Study+on+Asymptomatic+Sensitisation+and+Development+of+Allergic+Rhinitis%3A+High+Negative+Predictive+Value+of+Allergological+Testing&rft.jtitle=International+archives+of+allergy+and+immunology&rft.au=Bodtger%2C+Uffe&rft.au=Assing%2C+Kristian&rft.au=Poulsen%2C+Lars+K.&rft.date=2011-01-01&rft.issn=1018-2438&rft.eissn=1423-0097&rft.volume=155&rft.issue=3&rft.spage=289&rft.epage=296&rft_id=info:doi/10.1159%2F000320758&rft.externalDBID=n%2Fa&rft.externalDocID=10_1159_000320758 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1018-2438&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1018-2438&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1018-2438&client=summon |